把握黄金窗口期，开启阿尔茨海默病管理新范式——礼来制药董事长兼首席执行官戴文睿出席国际医药创新大会

新浪医药03-25

2024年3月22日，由中国国际经济交流中心（CCIEE）和中国外商投资企业协会（CAEFI）共同主办的第五届国际医药创新大会（以下简称：IPIF）在北京成功举办。来自政、产、学、研各领域的350余名嘉宾齐聚一堂，围绕医药创新，提升患者可及性等关键议题展开深入讨论。礼来制药董事长兼首席执行官戴文睿先生(David A. Ricks)受邀参会，并在“医药创新助力实现健康中国2030目标”全球CEO...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422563804?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-25 15:02","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2422563804","market":"us","top_or_hot":-1,"title":"把握黄金窗口期，开启阿尔茨海默病管理新范式——礼来制药董事长兼首席执行官戴文睿出席国际医药创新大会","media":"新浪医药","content":"<div>\n<p>2024年3月22日，由中国国际经济交流中心（CCIEE）和中国外商投资企业协会（CAEFI）共同主办的第五届国际医药创新大会（以下简称：IPIF）在北京成功举办。来自政、产、学、研各领域的350余名嘉宾齐聚一堂，围绕医药创新，提升患者可及性等关键议题展开深入讨论。礼来制药董事长兼首席执行官戴文睿先生(David A. Ricks)受邀参会，并在“医药创新助力实现健康中国2030目标”全球CEO...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251503238b5ff3ab&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>把握黄金窗口期，开启阿尔茨海默病管理新范式——礼来制药董事长兼首席执行官戴文睿出席国际医药创新大会</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n把握黄金窗口期，开启阿尔茨海默病管理新范式——礼来制药董事长兼首席执行官戴文睿出席国际医药创新大会\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-25 15:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251503238b5ff3ab&s=b><strong>新浪医药</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024年3月22日，由中国国际经济交流中心（CCIEE）和中国外商投资企业协会（CAEFI）共同主办的第五届国际医药创新大会（以下简称：IPIF）在北京成功举办。来自政、产、学、研各领域的350余名嘉宾齐聚一堂，围绕医药创新，提升患者可及性等关键议题展开深入讨论。礼来制药董事长兼首席执行官戴文睿先生(David A. Ricks)受邀参会，并在“医药创新助力实现健康中国2030目标”全球CEO...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251503238b5ff3ab&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0820561909.HKD","symbol_name":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251503238b5ff3ab&s=b","article_id":"2422563804","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251503238b5ff3ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2422563804","pubTimestamp":1711350165,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"礼来制药董事长兼首席执行官戴文睿先生受邀参会，并在“医药创新助力实现健康中国2030目标”全球CEO圆桌讨论中，围绕“推进中国阿尔茨海默病创新诊疗路径”发表了其观点洞见，强调了随着阿尔茨海默病突破性疗法的创新，其配套医疗管理系统向疾病早期阶段转移的重要性。与此同时，礼来积极与各方协作，推进完善AD诊疗路径、提升大众对于疾病的认知。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","BK4007":"制药","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","BK4588":"碎股","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","BK4581":"高盛持仓","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0238689110.USD":"贝莱德环球动力股票基金","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LLY":"礼来","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H"},"translate_title":"Grasp the Golden Window and Open a New Paradigm of Alzheimer's Disease Management--Dai Wenrui, Chairman and CEO of Lilly Pharmaceuticals, attended the International Pharmaceutical Innovation Conference","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"2024年3月22日，由中国国际经济交流中心（CCIEE）和中国外商投资企业协会（CAEFI）共同主办的第五届国际医药创新大会（以下简称：IPIF）在北京成功举办。来自政、产、学、研各领域的350余名嘉宾齐聚一堂，围绕医药创新，提升患者可及性等关键议题展开深入讨论。礼来制药董事长兼首席执行官戴文睿先生(David A. Ricks)受邀参会，并在“医药创新助力实现健康中国2030目标”全球CEO圆桌讨论中，围绕“推进中国阿尔茨海默病创新诊疗路径”发表了其观点洞见，强调了随着阿尔茨海默病（Alzheimer’s Disease, 以下简称：AD）突破性疗法的创新，其配套医疗管理系统向疾病早期阶段转移的重要性。建立完善的诊疗路径，提升早诊早治可及性AD是一种进行性进展的神经系统退行性疾病，防治的首要挑战在于该疾病的症状隐匿，难以在早期发现。同时，我国目前对于该疾病的管理和干预主要侧重于在疾病晚期阶段，早期发现、诊断和治疗系统尚未完备。据统计目前全球约不到一半的痴呆症患者得到了正式诊断，而大部分患者因未得到诊断错过了及时干预和治疗的“黄金窗口期”。戴文睿表示：“AD是引起痴呆症最常见的疾病，且具有致命性。目前，中国有近1000 万的AD患者，并预计在未来 20 年内增长4倍达至4000 万。这将需要患者家属投入大量的精力、财力、物力进行照料，为每个家庭造成了沉重的负担。”“因此，我们在此倡导将AD列入国家公共卫生的优先事项，聚焦基于生物标志物的早期检测与诊断，并积极采用PET-CT 等先进诊断技术。第二，完善院内外基础设施建设，在疾病早期阶段通过药物干预以减缓疾病进展，从而延长患者预期寿命并提高医疗系统效率。第三，将创新药物纳入保险计划中，以更广泛地惠及患者。”35载深耕，践行“健康老龄化”承诺作为全球神经退行性疾病领域的推动者和实践者，礼来在AD研发领域已深耕35年，投入了超80亿美元进行研发。与此同时，礼来积极与各方协作，推进完善AD诊疗路径、提升大众对于疾病的认知。在中国，礼来持续与相关患者组织沟通，并在多年间开展“全球员工志愿者服务日”等认知症关爱公益行动，积极呼吁社会关注AD患者未满足的需求、减少认知偏见，提升对AD群体及其家庭的关注。在2023年的中国国际进口博览会上，礼来在上海尽美老年服务中心的支持下，搭建起了一家 “记忆咖啡馆”， 开展期间数位AD患者为观众制作咖啡并交流互动，让更多人看到了AD患者们积极面对生活的态度，以消除大众对该疾病和患者群体的误解。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422563804"}